A Comparison of Scar Infiltration, Scar Deactivation, and Standard of Care for the Treatment of Chronic, Post-Surgical Pain After Cesarean Section
Completed · Not applicable
Conditions studied: Scar, Cesarean Section; Dehiscence
In brief
To compare scar infiltration with 0.5-1% Lidocaine at a dose of 3 mg/kg (max dose 300 mg) or scar deactivation with acupuncture surface release technique to determine which is more effective in reducing pain in adult patients with chronic, post-surgical pain related to the site of incision after low transverse Cesarean section compared to standard of care physical therapy with the McKenzie Method.
Key facts
- Study ID
- NCT03936309
- Run by
- Jennifer Loomis
- People needed
- 60
- Starts
- 2019-06-01
- Expected to finish
- 2025-04-08
- Last updated by the study team
- 2025-04-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female DoD beneficiaries age 18 years or older
- 3 months or greater postpartum with abdominal and/or back pain starting after low transverse Cesarean section scar.
- If subject has had prior Scar Deactivation with Surface Release Technique for cesarean section scar they must have completed a washout period of 12 weeks or more.
You may not qualify if…
- Pregnant
- Prior Scar Deactivation with Surface Release Technique for cesarean section scar within the last 12 weeks.
- Ever had Prior Scar Infiltration with Lidocaine for cesarean section.
- Active cellulitis surrounding scar
- Revision of Cesarean section scar
- Vertical incision or emergent Cesarean section
Where it is running
- 375th Medical Group — Scott Air Force Base, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.